| Download the app: Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. |
Related Subjects: |Emergency Drugs |Emergency Drug Antidotes |Emergency Cardiac Drugs |Emergency Endocrine Drugs |Emergency Gastrointestinal Drugs |Emergency Haematology Drugs |Emergency Neuropsychiatric drugs |Emergency Pain drugs |Emergency Respiratory drugs |Emergency Obstetric and Gynaecology Drugs |Emergency Paediatric Drugs
| DRUG (UK Name) | MOA | DOSE IV | DOSE PO | INDICATION | CONTRAINDICATION / CAUTION |
|---|---|---|---|---|---|
| Adenosine | Acts on A1 receptors in the AV node to transiently block conduction | 6 mg IV rapid push; if no effect, 12 mg IV after 1โ2 min; may repeat 12 mg once | N/A | Stable SVT, stable narrow complex tachycardia | Avoid in 2nd/3rd degree AV block without pacing; can cause transient bradycardia/asystole; check BNF for pregnancy |
| Amiodarone | Class III antiarrhythmic (K+ channel block), also Class I, II, IV effects |
VF/VT arrest: 300 mg IV push, then 150 mg if needed
Stable wide complex tachy: 150 mg IV over 10 min, then infusion (1 mg/min x6h, then 0.5 mg/min) |
N/A | VF/VT, wide complex tachyarrhythmias | Hypotension, potential proarrhythmia; long half-life; check BNF for pregnancy advice |
| Atropine | Anticholinergic, reduces vagal influence on SA/AV node |
Organophosphate poisoning: 1โ6 mg IV every 3โ5 min until secretions stop
Paediatric bradycardia: 0.02 mg/kg IV once (max single 0.5 mg, max total 1 mg) Adult bradycardia: 0.5 mg IV every 3โ5 min (max 3 mg) |
N/A | Bradycardia, organophosphate/carbamate poisoning | Hyperthermia, tachyarrhythmias; consult BNF for pregnancy |
| Calcium Gluconate/Chloride | Increases serum Caยฒโบ, stabilises cardiac membrane | Typically 10% solution: 1 g (in 10 mL) IV | N/A | Hyperkalaemia, hypocalcaemia with arrhythmias | CaCl is more irritant and 3x more potent than Ca gluconate; central line preferred for CaCl; check BNF for pregnancy |
| Diltiazem | Non-dihydropyridine Caยฒโบ channel blocker; slows AV conduction | 0.25 mg/kg IV bolus, may repeat 0.35 mg/kg IV after 15 min; infusion 5โ15 mg/h | N/A | Stable AF with RVR, stable SVT | May cause hypotension, bradycardia; use caution in heart failure; check BNF for pregnancy |
| Dobutamine | Beta-1 agonist (with some Beta-2) | 2โ20 micrograms/kg/min IV infusion | N/A | Acute heart failure, cardiogenic shock | Tachycardia, arrhythmias; ensure adequate volume status; check BNF for pregnancy |
| Dopamine | Alpha, Beta-1, and dopaminergic receptor agonist (dose-dependent) |
<5 micrograms/kg/min (renal/dopaminergic - not typically recommended)
5โ10 micrograms/kg/min (beta effects) 10โ20 micrograms/kg/min (alpha effects) |
N/A | Hypotension, heart failure | Arrhythmias, tissue necrosis with extravasation (use central line); check BNF for pregnancy |
| Adrenaline (Epinephrine) | Alpha and Beta agonist |
Cardiac arrest: 1 mg of 1:10,000 IV every 3โ5 min
Anaphylaxis: 0.5 mg of 1:1,000 IM (adults) Hypotension/shock: 1โ10 micrograms/min IV infusion (titrate) |
N/A | Cardiac arrest, anaphylaxis, severe hypotension, severe asthma | Risk of arrhythmias, extravasation injury; verify doses carefully; consult BNF for pregnancy |
| Esmolol | Short-acting selective Beta-1 blocker | 500 micrograms/kg IV loading, then 50โ300 micrograms/kg/min infusion | N/A | Aortic dissection (rate control), arrhythmias | Can precipitate heart failure, hypotension, bronchospasm; check BNF for pregnancy |
| Furosemide (Frusemide) | Loop diuretic inhibiting Naโบ/Kโบ/2Clโป in ascending loop | 20โ40 mg IV initially, reassess; can go up to 200 mg single dose if needed | N/A | Acute pulmonary oedema, fluid overload states | Hypovolaemia, electrolyte depletion, ototoxicity; check BNF for pregnancy |
| Labetalol | Combined alpha and beta blocker | Bolus: 20โ80 mg IV every 10 min PRN; Infusion: 1โ8 mg/min titrated | N/A | Hypertensive emergencies | Can precipitate heart failure, bradycardia, bronchospasm; check BNF for pregnancy |
| Magnesium Sulfate | Essential electrolyte, membrane stabiliser, reduces neuromuscular excitability |
Eclampsia: 2โ4 g IV load over ~5 min
Torsades: 2 g IV push Asthma: 2 g IV over 15 min |
N/A | Eclampsia, torsades de pointes, severe asthma | Hypotension if given rapidly, respiratory depression if overdosed; safe in pregnancy (commonly used for eclampsia) |
| Glyceryl Trinitrate (GTN, Nitroglycerin) | Venodilator, increases cGMP | 5โ200 micrograms/min IV, increase by 10 micrograms every 3โ5 min until desired effect | N/A | Angina, CHF, acute pulmonary oedema | Hypotension, headache, rare methemoglobinaemia; check BNF for pregnancy |
| Sodium Nitroprusside | Direct vasodilator via NO release | Start at 0.3 micrograms/kg/min IV, titrate; max 10 micrograms/kg/min. If no control after 10 min at max, stop. | N/A | Hypertensive emergencies | Cyanide toxicity (prolonged infusion), methemoglobinaemia, hypotension; check BNF for pregnancy |
| Norepinephrine (Noradrenaline) | Potent alpha-1 > beta-1 agonist | 1โ30 micrograms/min IV infusion (titrate to BP) | N/A | Refractory hypotension (septic shock, other shock states) | Arrhythmias, extravasation injury (use central line); check BNF for pregnancy |